NCT04924894

Brief Summary

Despite the global preventive efforts (physical distancing, face, mask, travel constraints, and quarantine) to contain the infection, COVID-19 is continuing with its devastating consequences on health, life, and economics. The world's hopes are attached to a successful preventive measure that is the vaccination which has proved its capability to stop infections and save lives over the years. World Health Organization (WHO) declared vaccination hesitancy as one of the top 10 obstacles for global health. Multicentric study involved Arab countries measure hesitancy of HCWs toward vaccine, it reported the highest rates of hesitancy were among participants from the western regions of the Arab world (Egypt, Morocco, Tunisia, and Algeria). This study aims to evaluate the attitude and the determinants of this attitude of HCWs towards receiving or refusing to have their first dose of vaccination.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

June 10, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

June 14, 2021

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

June 10, 2021

Last Update Submit

June 10, 2021

Conditions

Keywords

COVID-19, Vaccine, acceptance, attitude

Outcome Measures

Primary Outcomes (1)

  • The rate of acceptance among HCWs who offered COVID-19 vaccine

    to evaluate the rate of acceptance or refusal of receiving COVID-19 vaccines among health care workers

    baseline

Secondary Outcomes (1)

  • 1. Reasons for acceptance 2. Reasons for refusal 1. Reasons for acceptance 2. Reasons for refusal the response for COVID-19 vaccination acceptance or refusal

    baseline

Interventions

no intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All healthcare workers in Assiut university hospitals how are eligible for COVID-19 vaccination and the vaccine is freely offered to them

You may qualify if:

  • All staff how are working in AUH and offered to receive the first dose of AstraZeneca \& Sino pharm vaccine.

You may not qualify if:

  • Those who are not eligible to receive the vaccine
  • Those who are not freely offered to receive the vaccine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study. Vaccines (Basel). 2021 May 2;9(5):446. doi: 10.3390/vaccines9050446.

    PMID: 34063313BACKGROUND
  • Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 2020 Oct 3;8(4):582. doi: 10.3390/vaccines8040582.

    PMID: 33022917BACKGROUND

MeSH Terms

Conditions

COVID-19Behavior

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 14, 2021

Study Start

June 10, 2021

Primary Completion

November 30, 2021

Study Completion

June 10, 2022

Last Updated

June 14, 2021

Record last verified: 2021-06